Related Experiment Videos
Necrotizing scleritis following diode laser transscleral cyclophotocoagulation
Sunny Y Shen1, Jimmy S M Lai, Dennis S C Lam
1Department of Ophthalmology, United Christian Hospital, Kowloon, Hong Kong.
Summary
Necrotizing scleritis developed in a patient 10 months after diode laser cyclophotocoagulation for neovascular glaucoma. This suggests diode laser cyclophotocoagulation may pose risks for patients with potential systemic vasculitic diseases.
Area of Science:
- Ophthalmology
- Vascular Diseases
Background:
- Neovascular glaucoma is a severe condition often treated with diode laser cyclophotocoagulation.
- Systemic vasculitic diseases can affect ocular tissues and present diagnostic challenges.
Observation:
- A 23-year-old woman experienced necrotizing scleritis with scleral thinning and uveal prolapse.
- These complications arose 10 months post-diode laser cyclophotocoagulation for neovascular glaucoma.
Findings:
- The patient's necrotizing scleritis and staphyloma progression were managed with systemic steroids.
- Diode laser cyclophotocoagulation might be unsafe in individuals with suspected systemic vasculitis.
Implications:
- Ophthalmologists should consider underlying systemic vasculitic diseases before performing diode laser cyclophotocoagulation.
- Early recognition and management of scleritis post-procedure are crucial for visual preservation.